Patrizia Ferrero serves as the Global Marketing Director for Growth Brands at Norgine, where she plays a pivotal role in steering the strategic direction of the company’s existing product portfolio across Western Europe and Australia. With direct oversight of brand managers within local affiliates, she...
Patrizia Ferrero serves as the Global Marketing Director for Growth Brands at Norgine, where she plays a pivotal role in steering the strategic direction of the company’s existing product portfolio across Western Europe and Australia. With direct oversight of brand managers within local affiliates, she is instrumental in orchestrating marketing initiatives that align with the company's objectives, ensuring that the Growth Brands Business Unit not only meets but exceeds its financial targets. Patrizia manages a substantial marketing budget of approximately €20 million, with the ambitious goal of driving revenues to around €180 million.
Her expertise spans various critical areas, including pharmaceutical sales, product marketing, and market research, which she leverages to enhance brand visibility and market penetration. By fostering a culture of collaboration and innovation among her team, she ensures that brand strategies are effectively executed and tailored to meet the unique needs of each market. Patrizia’s leadership is characterized by her ability to navigate the complexities of the pharmaceutical landscape, particularly in cardiology and hospital sales, while maintaining compliance with regulatory affairs.
In her role, she collaborates closely with the Global Brand Director to refine marketing strategies that resonate with healthcare professionals and patients alike. Her commitment to sales effectiveness and team development has not only strengthened brand performance but also cultivated a high-performing team that is agile and responsive to market dynamics. Through her strategic vision and hands-on management style, Patrizia Ferrero continues to drive growth and innovation within Norgine’s portfolio, positioning the company for sustained success in the competitive pharmaceutical industry.
